1. Home
  2. CCTG vs GDTC Comparison

CCTG vs GDTC Comparison

Compare CCTG & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCSC Technology International Holdings Limited

CCTG

CCSC Technology International Holdings Limited

HOLD

Current Price

$0.61

Market Cap

8.9M

Sector

N/A

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.84

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCTG
GDTC
Founded
1993
2018
Country
Hong Kong
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
10.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
CCTG
GDTC
Price
$0.61
$0.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
97.5K
18.5K
Earning Date
12-23-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$0.68
52 Week High
$5.64
$3.68

Technical Indicators

Market Signals
Indicator
CCTG
GDTC
Relative Strength Index (RSI) 40.72 39.88
Support Level $0.38 $0.73
Resistance Level $0.65 $1.08
Average True Range (ATR) 0.05 0.09
MACD -0.00 -0.01
Stochastic Oscillator 15.47 13.91

Price Performance

Historical Comparison
CCTG
GDTC

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd, through its direct wholly-owned subsidiaries, is principally engaged in the manufacturing and sale of interconnect products, including connectors, cables and wire harnesses. The company produces both original equipment manufacturer (OEM) and original design manufacturer (ODM) interconnect products for manufacturing companies that produce end products, as well as for electronic manufacturing services (EMS) companies. The majority of the company's revenue is derived from the sale of Cable and wire harnesses, and Connectors. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: